Literature DB >> 31234013

The roles of heavy drinking and drug use in engagement in HIV care among hospitalized substance using individuals with poorly controlled HIV infection.

Jennifer C Elliott1, Lacey Critchley2, Daniel J Feaster2, Deborah S Hasin3, Raul N Mandler4, Georgina Osorio5, Allan E Rodriguez6, Carlos Del Rio7, Lisa R Metsch8.   

Abstract

BACKGROUND: Substance use can reduce care engagement for individuals with HIV. However, little is known as to whether heavy drinkers differ from drug users. This study compares heavy drinkers, drug users, and those drinking heavily and using drugs on their HIV care engagement.
METHODS: HIV-infected adult inpatients (n = 801; 67% male; 78% Black) from 11 urban hospitals across the United States participated in a multisite clinical trial to improve patient engagement in HIV care and virologic outcomes. All participants drank heavily and/or used drugs, and had poorly controlled HIV. Participants reported care history at baseline. We compared heavy drinkers, drug users, and those both drinking heavily and using drugs (reference group) on their engagement in care.
RESULTS: Heavy drinkers reported lowest rates of lifetime HIV care, AOR = 0.59 (95% CI = 0.36, 0.97). Groups did not differ in recent care, prescription of HIV medication, medical mistrust, or patient-provider relationship. Drug users evidenced the best medication adherence, AOR = 2.38 (95% CI = 1.33, 4.23). Exploratory analyses indicated that drinkers had lower initial care engagement, but that it increased more rapidly with duration of known HIV infection, with similar rates of recent care. Drinkers had the lowest CD4 counts (B=-0.28, p < 0.0001), but no difference in viral load.
CONCLUSIONS: Heavy drinkers were least likely to have ever been in HIV care. More research is needed to determine why heavy drinkers evidence the lowest initial care engagement and current CD4 counts, and whether drinking intervention early in infection may increase HIV care engagement.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol; Care engagement; Drug; HIV; Treatment

Year:  2019        PMID: 31234013      PMCID: PMC6677390          DOI: 10.1016/j.drugalcdep.2019.03.024

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  25 in total

Review 1.  A comprehensive review of the psychometric properties of the Drug Abuse Screening Test.

Authors:  Errol Yudko; Olga Lozhkina; Adriana Fouts
Journal:  J Subst Abuse Treat       Date:  2006-11-21

2.  Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.

Authors:  Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Tim Matheson; Maxine Stitzer; Moupali Das; Mamta K Jain; Allan E Rodriguez; Wendy S Armstrong; Gregory M Lucas; Ank E Nijhawan; Mari-Lynn Drainoni; Patricia Herrera; Pamela Vergara-Rodriguez; Jeffrey M Jacobson; Michael J Mugavero; Meg Sullivan; Eric S Daar; Deborah K McMahon; David C Ferris; Robert Lindblad; Paul VanVeldhuisen; Neal Oden; Pedro C Castellón; Susan Tross; Louise F Haynes; Antoine Douaihy; James L Sorensen; David S Metzger; Raul N Mandler; Grant N Colfax; Carlos del Rio
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

3.  Substance use and the quality of patient-provider communication in HIV clinics.

Authors:  P Todd Korthuis; Somnath Saha; Geetanjali Chander; Dennis McCarty; Richard D Moore; Jonathan A Cohn; Victoria L Sharp; Mary Catherine Beach
Journal:  AIDS Behav       Date:  2011-05

Review 4.  A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization.

Authors:  Marwan M Azar; Sandra A Springer; Jaimie P Meyer; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2010-08-11       Impact factor: 4.492

Review 5.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

6.  The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening.

Authors:  Hayley S Thompson; Heiddis B Valdimarsdottir; Gary Winkel; Lina Jandorf; William Redd
Journal:  Prev Med       Date:  2004-02       Impact factor: 4.018

7.  Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care - Washington, DC.

Authors:  Amanda D Castel; Mariah M Kalmin; Rachel L D Hart; Heather A Young; Harlen Hays; Debra Benator; Princy Kumar; Richard Elion; David Parenti; Maria Elena Ruiz; Angela Wood; Lawrence D'Angelo; Natella Rakhmanina; Sohail Rana; Maya Bryant; Annick Hebou; Ricardo Fernández; Stephen Abbott; James Peterson; Kathy Wood; Thilakavathy Subramanian; Jeffrey Binkley; Lindsey Powers Happ; Michael Kharfen; Henry Masur; Alan E Greenberg
Journal:  AIDS Care       Date:  2016-06-13

8.  HIV-positive patients' discussion of alcohol use with their HIV primary care providers.

Authors:  Lisa R Metsch; Margaret Pereyra; Grant Colfax; Carol Dawson-Rose; Gabriel Cardenas; David McKirnan; Dogan Eroglu
Journal:  Drug Alcohol Depend       Date:  2008-02-19       Impact factor: 4.492

9.  A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse.

Authors:  Kamini E Kuchinad; Heidi E Hutton; Anne K Monroe; Garrick Anderson; Richard D Moore; Geetanjali Chander
Journal:  BMC Res Notes       Date:  2016-04-22

10.  Exploring How Substance Use Impedes Engagement along the HIV Care Continuum: A Qualitative Study.

Authors:  Marya Gwadz; Rebecca de Guzman; Robert Freeman; Alexandra Kutnick; Elizabeth Silverman; Noelle R Leonard; Amanda Spring Ritchie; Corinne Muñoz-Plaza; Nadim Salomon; Hannah Wolfe; Christopher Hilliard; Charles M Cleland; Sylvie Honig
Journal:  Front Public Health       Date:  2016-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.